Astrada

Name: Astrada
Brand: Astrada

AI Native

The unified API for real-time transaction feeds

Est 2024|Raised $3.8M|4 Ref Customers

LinkedIn 1K|Website|FTEs 43|HQ San Francisco, CA

01Competitive Landscape

| Aspect | Astrada (vendor website) | CCH Tagetik (Wolters Kluwer) | Anaplan | |--------|---------------|----------------|----------------| | Starting Price | Not publicly listed (quote-based) | Typically enterprise quote-based | Quote-based, enterprise pricing | | Primary use cases | Organizations needing costing/profitability allocations, healthcare KPS/PKS support, scheduling optimization with local constraints | Enterprise CPM/EPM: consolidation, planning, profitability, ESG/reporting | Connected planning across functions; flexible planning models | | Key strengths | Domain-specific decision support; evidence of regional healthcare deployments in Sweden; focus on traceability and multi-dimensional profitability | Broad platform breadth, enterprise features, vendor scale and ecosystem | Flexible planning platform; widely adopted for cross-functional planning | | Key weaknesses | Limited public security documentation; limited independent review footprint; documented integration/data correctness issues in audit contexts | Can be complex and implementation-heavy; requires significant governance | Pricing and governance complexity depending on implementation approach |

Narrative competitive analysis

Astrada vs enterprise EPM/CPM suites (Tagetik/Oracle/SAP)
- Astrada is more specialized and appears aligned to Swedish public-sector healthcare workflows, whereas large suites provide broader enterprise standardization, published compliance attestations, larger partner ecosystems, and broader functionality.
Astrada vs Anaplan
- Anaplan is a generalized connected planning platform; Astrada is more solution-focused in costing/profitability and healthcare operations contexts. Buyers may favor Astrada where a more packaged, domain-specific tool is suitable, and choose platforms like Anaplan when broad, cross-functional planning standardization is required.
Astrada vs Swedish healthcare costing/planning vendors (e.g., Insera for CPP/KPP)
- Insera is positioned around Cost Per Patient (CPP/KPP) per Swedish guidelines. Buyers should evaluate alignment with Swedish methodologies and interoperability with regional data sources when comparing vendors.

01Competitive Landscape

Aspect	Astrada (vendor website)	CCH Tagetik (Wolters Kluwer)	Anaplan
Starting Price	Not publicly listed (quote-based)	Typically enterprise quote-based	Quote-based, enterprise pricing
Primary use cases	Organizations needing costing/profitability allocations, healthcare KPS/PKS support, scheduling optimization with local constraints	Enterprise CPM/EPM: consolidation, planning, profitability, ESG/reporting	Connected planning across functions; flexible planning models
Key strengths	Domain-specific decision support; evidence of regional healthcare deployments in Sweden; focus on traceability and multi-dimensional profitability	Broad platform breadth, enterprise features, vendor scale and ecosystem	Flexible planning platform; widely adopted for cross-functional planning
Key weaknesses	Limited public security documentation; limited independent review footprint; documented integration/data correctness issues in audit contexts	Can be complex and implementation-heavy; requires significant governance	Pricing and governance complexity depending on implementation approach

Narrative competitive analysis

Astrada vs enterprise EPM/CPM suites (Tagetik/Oracle/SAP)
- Astrada is more specialized and appears aligned to Swedish public-sector healthcare workflows, whereas large suites provide broader enterprise standardization, published compliance attestations, larger partner ecosystems, and broader functionality.
Astrada vs Anaplan
- Anaplan is a generalized connected planning platform; Astrada is more solution-focused in costing/profitability and healthcare operations contexts. Buyers may favor Astrada where a more packaged, domain-specific tool is suitable, and choose platforms like Anaplan when broad, cross-functional planning standardization is required.
Astrada vs Swedish healthcare costing/planning vendors (e.g., Insera for CPP/KPP)
- Insera is positioned around Cost Per Patient (CPP/KPP) per Swedish guidelines. Buyers should evaluate alignment with Swedish methodologies and interoperability with regional data sources when comparing vendors.

Astrada

01Competitive Landscape

Narrative competitive analysis

02Market Map

01Competitive Landscape

Narrative competitive analysis

02Market Map